Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation
Conditions: Multiple Myeloma - Blood and Marrow Transplant (BMT)
1 Location available
- VEGF Trap in Treating Patients With Stage II or Stage III Multiple Myeloma That Has Relapsed or Not Responded to Previous Treatment
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
5 Locations available
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloid
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary S
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Conditions: Ovarian Cancer - Renal Cancer - Non-small Cell Lung Cancer - Small Cell Lung Cancer - Solid Tumors - Multiple Myeloma
7 Locations available
- Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Trans
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndrome - Acute Lymphocytic Leukemia - Relapsed/Refractory Chronic Lymphocytic Leukemia - Relapsed/Refractory Non Hodgkin's Lymphoma - Hodgkins Disease - Relapsed Refractory Multiple Myeloma
2 Locations available
- Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies
Conditions: Multiple Myeloma - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - Non Hodgkin's Lymphoma - Waldenstroms - Mantle Cell Lymphoma
1 Location available
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Ca
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
5 Locations available
- Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma
Conditions: Advanced Cancer, Various, NOS
6 Locations available
- Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Conditions: Leukemia - Lymphoma - Multiple Myeloma - Plasma Cell Neoplasm - Myelodysplastic Syndromes
4 Locations available
- Dose-escalation Study of Oral CX-4945
Conditions: Advanced Solid Tumors - Breast Cancer - Inflammatory Breast Cancer - Castleman's Disease - Multiple Myeloma
4 Locations available
- Ph II of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
Conditions: Transplantation, Homologous - Transplantation, Autologous - Multiple Myeloma - Blood and Marrow Transplant (BMT)
1 Location available
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Un
2 Locations available
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
140 Locations available
- Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Conditions: Lymphoma - Multiple Myeloma - Plasma Cell Neoplasm
2 Locations available
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By an Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in T
Conditions: Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
Conditions: Lymphoma - Leukemia - Multiple Myeloma - Lymphoid Malignancies
1 Location available
- Phase 1 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma
5 Locations available
- Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
Conditions: Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm
2 Locations available
- Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated M
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Therapeutic Research in Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors
Conditions: Hematologic Neoplasms - Anemia, Aplastic - Hemoglobinuria, Paroxysmal - Multiple Myeloma
1 Location available
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
113 Locations available
- Lenalidomide and Dexamethasone With/Without Transplant in Patients With Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell Transplant
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
1 Location available
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
440 Locations available
- Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
Conditions: Hematopoietic/Lymphoid Cancer - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - B-cell Adult Acute Lymphoblastic Leukemia - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associate
2 Locations available
- Host Dendritic Cells in Allograft Patients
Conditions: Relapsed Non-Hodgkin's Lymphoma - Hodgkin's Disease - Multiple Myeloma - Chronic Lymphocytic Lymphoma
1 Location available
- Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
2 Locations available
- Study of Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) to Treat Hematologic Malignancies and Hematopoietic Failure S
Conditions: Hematologic Neoplasms - Multiple Myeloma - Anemia, Aplastic - Hemoglobinuria, Paroxysmal - Myelofibrosis
1 Location available
- Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Conditions: Refractory Multiple Myeloma
5 Locations available
- Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II
Conditions: Refractory Multiple Myeloma - Smoldering Multiple Myeloma - Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
1 Location available
- Stem Cell Transplant for Hematological Malignancy
Conditions: Leukemia, Myeloid, Chronic - AML - Leukemia, Lymphocytic, Acute - MDS - Leukemia, Lymphocytic, Chronic - JMML - Hodgkin's Disease - Non-hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage
Conditions: Refractory Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
4 Locations available
- Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
Conditions: Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Conditions: Myelodysplastic Syndrome - Hodgkin's Lymphoma - Non-Hodgkin's Disease - Acute Leukemia - Multiple Myeloma
1 Location available
- Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Intensity-Modulated Radiation Therapy, Fludarabine, and Melphalan Followed by a Donor Stem Cell Transplant in Treating Patients With Hematological Can
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- A Phase II Study of Umbilical Cord Blood Transplantation
Conditions: Leukemia - Lymphoma - Multiple Myeloma - Aplastic Anemia
1 Location available
- Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance RX
Conditions: Multiple Myeloma
1 Location available
- Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
7 Locations available
- Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
4 Locations available
- Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndromes - Lymphoma - Multiple Myeloma - Leukemia, Myelomonocytic, Chronic
4 Locations available
- Fludarabine, Melphalan, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Dis
Conditions: Chronic Myeloproliferative Disorders - Fanconi Anemia - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Paroxysmal Nocturnal Hemoglobinuria
1 Location available
- A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic
Conditions: Lymphoma, Mantle-Cell - Leukemia, Lymphocytic, Chronic, B-Cell - Leukemia, Hairy Cell - Waldenstrom Macroglobulinemia - Multiple Myeloma
1 Location available
- Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Conditions: Breast Cancer - Hypercalcemia of Malignancy - Colon Cancer - Endocrine Cancer - Head and Neck Cancer - Kidney Cancer - Lung Cancer - Lymphoma - Metastatic Cancer - Multiple Myeloma - Parathyroid Neoplasms - Renal Cancer - Thyroid Cancer - Hodgkin's Lympho
9 Locations available
- Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral MLN9708 in Adult Patients With Relapsed and Refractory Multiple Myeloma
Conditions: Relapsed and Refractory Multiple Myeloma
6 Locations available
- Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Post Transplant Donor Lymphocyte Infusion
Conditions: Leukemia, Myeloid, Chronic - Lymphomas - Multiple Myeloma - Myelodysplastic Syndrome - Leukemia, Lymphocytic, Acute - Leukemia, Lymphocytic, Chronic - AML
1 Location available
- Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Conditions: Lymphoma - Leukemia - Multiple Myeloma - Colon Cancer - Renal Cancer
1 Location available
- Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
Conditions: Multiple Myeloma - Primary Amyloidosis
1 Location available
- UARK 2008-01, Total Therapy 4 - A Phase III Trial for Low Risk Myeloma
Conditions: Multiple Myeloma
1 Location available
- Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
Conditions: Leukemia - Lymphoma, Non-Hodgkin - Hodgkin Disease - Myelodysplastic Syndromes - Multiple Myeloma
1 Location available
- Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm - Precancerous Condition
1 Location available
- Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients
Conditions: Cancer - Myeloma - Multiple Myeloma
1 Location available
- Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantat
Conditions: Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemias - Multiple Myeloma With Plasmacytoma
1 Location available
- IMGN901 in Combination With Lenalidomide and Dexamethasone
Conditions: Multiple Myeloma
5 Locations available
- Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
Conditions: Multiple Myeloma
39 Locations available
- Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF
Conditions: Multiple Myeloma
1 Location available
- Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study
Conditions: Multiple Myeloma
1 Location available
- Blockage of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
Conditions: Multiple Myeloma
2 Locations available
- Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma
Conditions: Refractory Multiple Myeloma - Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
1 Location available
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
252 Locations available
- Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphoc
Conditions: Multiple Myeloma
1 Location available
- Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
Conditions: Refractory Multiple Myeloma
2 Locations available
- A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma
Conditions: Fatigue - Multiple Myeloma
3 Locations available
- Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First
Conditions: Patients With Multiple Myeloma Experiencing a - First or Second Relapse
5 Locations available
- Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Precancerous Condition - Secondary Myelofibrosis
1 Location available
- Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
2 Locations available
- UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide
Conditions: Multiple Myeloma
1 Location available
- ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Metastatic Bone Tumors for the Palliation of Pain
Conditions: Bone Metastases - Multiple Myeloma
8 Locations available
- A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Relapsed or Refractory Multiple Myeloma
6 Locations available
- Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk
Conditions: Refractory Multiple Myeloma - Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
1 Location available
- Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
Conditions: Multiple Myeloma - End Stage Renal Disease
1 Location available
- Collecting Samples From Patients With Primary Systemic Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
5 Locations available
- Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects
Conditions: Multiple Myeloma
1 Location available
- Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Refractory Multiple Myeloma
6 Locations available
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
113 Locations available
- Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
Conditions: Multiple Myeloma and Plasma Cell Neoplasm - Thromboembolism
1 Location available
- Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Nonmalignant Neoplasm
1 Location available
- Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma
Conditions: Multiple Myeloma
1 Location available
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
8 Locations available
- Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
Conditions: Multiple Myeloma
2 Locations available
- Escalating Doses Thalidomide+Bortezomib+HIgh Dose Melphalan for Auto PBSC Transplant in Patients With Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm
4 Locations available
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
309 Locations available
- Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Conditions: MDS - AML - Solid Tumors - Multiple Myeloma - Non-Hodgkin's Lymphoma - Hodgkin's Disease
8 Locations available
- High-Dose Melphalan and Stem Cell Transplant in Treating Patients With Immunoglobulin Deposition Disease or Light-Chain Deposition Disease
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma - Plasma Cell Leukemia
5 Locations available
- Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Conditions: Multiple Myeloma
2 Locations available
- Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies
Conditions: Non-hodgkins Lymphoma - Hodgkins Lymphoma - Multiple Myeloma
1 Location available
- Omega 3 Supplementation for the Prevention of Disease Progression in Early Stage Chronic Lymphocytic Leukemia (ES-CLL), Monoclonal Gammopathy of Undet
Conditions: Chronic Lymphocytic Leukemia (CLL Enrollment Maximum Has Been Met) - Monoclonal Gammopathy of Undetermined Significance - Smoldering Multiple Myeloma
1 Location available
- Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- SCRI TISSUE TESTING REGISTRY
Conditions: Melanoma - Myelodysplastic Syndrome - Multiple Myeloma - Lymphoma
1 Location available
- Compassionate Use Study of Carfilzomib
Conditions: Multiple Myeloma
1 Location available
- A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma
Conditions: Multiple Myeloma
2 Locations available
- Comparative Trial of Cryotherapy Versus Caphosol Versus Saline Solution Mouth Washes for the Prevention of Oral Mucositis in Patients With Multiple My
Conditions: Mucositis - Multiple Myeloma
1 Location available
- Dose Escalation Study of INK128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom Macroglobulinemia
Conditions: Relapsed or Refractory Multiple Myeloma - Waldenstrom Macroglobulinemia
4 Locations available
- Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myelo
Conditions: Lymphoma, Non-Hodgkin - Hodgkin Disease - Multiple Myeloma
9 Locations available
- AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
Conditions: Multiple Myeloma - Leukemia - MGUS - MBL
2 Locations available
- Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma
Conditions: Multiple Myeloma - Auto Stem Cell Transplant
1 Location available
- A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma
Conditions: Myeloma - Smoldering Multiple Myeloma
1 Location available
- Carfilzomib Plus Panobinostat in Relapsed/Refractory Multiple Myeloma (MM)
Conditions: Myeloma
1 Location available
- Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma
Conditions: Smoldering Multiple Myeloma
9 Locations available
- Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)
Conditions: Multiple Myeloma
1 Location available
- A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma, Plasma Cell Leukemia
3 Locations available
- Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
Conditions: Multiple Myeloma
5 Locations available
- Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency
Conditions: Multiple Myeloma - Renal Insufficiency
5 Locations available
- Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
Conditions: Multiple Myeloma
1 Location available
- Phase I/II Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments
Conditions: Multiple Myeloma
8 Locations available
- Arry-520 + Carfilzomib for Multiple Myeloma (MM)
Conditions: Myeloma
1 Location available
- Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization
Conditions: Multiple Myeloma
1 Location available
- Open-label Study of TH-302 as Monotherapy and in Combination With Bortezomib in Subjects With Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma
2 Locations available
- Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM)
Conditions: Myeloma
1 Location available
- A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
9 Locations available
- Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
9 Locations available
- Total Skeletal Irradiation in Multiple Myeloma Before Second Autologous Hematopoietic Stem Cell Transplantation
Conditions: Multiple Myeloma
1 Location available
- Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma
Conditions: Multiple Myeloma - Relapsed Multiple Myeloma - Refractory Multiple Myeloma
5 Locations available
- Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Refractory Multiple Myeloma
1 Location available
- A Study of Carfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Study of Oral MLN9708 in Combination With Melphalan and Prednisone in Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma
3 Locations available
- MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Conditions: Multiple Myeloma
3 Locations available
- Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple M
Conditions: Solid Tumors - Non-Hodgkin's Lymphoma - Multiple Myeloma
2 Locations available
- 90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed By Donor Peripheral Blood Stem Cell Transplant in Treati
Conditions: Refractory Multiple Myeloma - Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
1 Location available
- High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant
Conditions: Refractory Multiple Myeloma - Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
1 Location available
- Imaging Studies and the Development of Multiple Myeloma
Conditions: Multiple Myeloma - Smoldering Multiple Myeloma - Monoclonal Gammopathy of Undetermined Significance
1 Location available
- GDC-0449 in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma Who Received an Autologous Stem Cell Transplant
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
2 Locations available
- Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research
Conditions: Multiple Myeloma
1 Location available
- Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
Conditions: Multiple Myeloma
1 Location available
- Panobinostat and Everolimus for Multiple Myeloma or Lymphoma
Conditions: Multiple Myeloma
2 Locations available
- Id-KLH Vaccine + T Cells
Conditions: Multiple Myeloma
1 Location available
- Phase 1/2 Safety and Tolerability Study of SNS01-T in Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma - Multiple Myeloma in Relapse - Refractory Multiple Myeloma
3 Locations available
- c-Met Inhibitor ARQ 197 (Tivantinib) in Treating Patients With Relapsed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- A Study of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Using a Conditioning Regimen of Fludarabine, Melphalan, and Bortezo
Conditions: Multiple Myeloma
1 Location available
- A Safety Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
6 Locations available
- Carfilzomib for Relapsed and Unresponsive Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or
Conditions: Multiple Myeloma
6 Locations available
- Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens
Conditions: Multiple Myeloma
1 Location available
- Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukem
Conditions: Leukemia - Non-Hodgkins Lymphoma - Hodgkins Lymphoma - MDS - Multiple Myeloma
1 Location available
- Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
Conditions: Cancer Survivor - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Testicular Germ Cell Tumor
1 Location available
- Sirolimus, Tacrolimus, Antithymocyte Globulin, and Rituximab in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancers or Other Dis
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Conditions: Multiple Myeloma - Waldenstrom's Macroglobulinemia - Smoldering Multiple Myeloma - Lymphoblastic Lymphoma
1 Location available
- Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
6 Locations available
- Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma
Conditions: Multiple Myeloma
2 Locations available
- Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide
Conditions: Refractory Multiple Myeloma
1 Location available
- Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
Conditions: Hodgkin's Lymphoma - Leukemia - Myelodysplastic Syndrome(MDS) - Multiple Myeloma - Non Hodgkin's Lymphoma
1 Location available
- Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Conditions: Multiple Myeloma - Non-Hodgkin's Lymphoma - Glioblastoma Multiforme - Head and Neck Squamous Cell Cancer - Triple Negative Breast Cancer - Hormone Receptor-Positive Breast Cancer - Castration-Resistant Prostate Cancer - Ewing's Family of Sarcomas
2 Locations available
- Tandem: Mel-Mel/Vel
Conditions: Multiple Myeloma
1 Location available
- Fractionated Stem Cell Infusions in Myeloma Patients Undergoing Autologous Stem Cell Transplant
Conditions: Multiple Myeloma
1 Location available
- A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
3 Locations available
- Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Conditions: Acute Lymphoid Leukemia - Acute Myeloid Leukemia - Chronic Lymphocytic Leukemia - Multiple Myeloma - Solid Tumors
18 Locations available
- Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
16 Locations available
- Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Conditions: Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Chronic Lymphocytic Leukemia - Chronic Myelogenous Leukemia - Hodgkins Disease - Non-Hodgkins Lymphoma - Aplastic Anemia - Multiple Myeloma - Myelodysplastic Syndrome
1 Location available
- Carfilzomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies
Conditions: Hematologic Neoplasms - Leukemia - Lymphoma - Multiple Myeloma - Hodgkin's Disease
1 Location available
- Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma
45 Locations available
- Proteasome Inhibitor MLN9708 in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib
Conditions: Multiple Myeloma
3 Locations available
- Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
Conditions: Multiple Myeloma
1 Location available
- Providing Access to Cord Blood Units for Transplants
Conditions: Chronic Myelogous Leukemia/Other Leukemia - Acute Leukemias - MDS/MPS - Multiple Myeloma - Non-Hodgkin Lymphoma
1 Location available
- A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
1 Location available
- ACE-011 With Lenalidomide+Dexamethasone for Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
Conditions: Leukemia - Acute Myeloid Leukemia - Acute Lymphocytic Leukemia - Chronic Myeloid Leukemia - Chronic Lymphocytic Leukemia - Myeloproliferative Diseases - Non-Hodgkins Lymphoma - Hodgkins Lymphoma - Multiple Myeloma - Myelodysplastic Syndrome
1 Location available
- Study of Intravenous Busulfan in Combination With Melphalan and Bortezomib in Patients With Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Autologous Transplant for Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing an Umbilical Cord Blood Transplant for Hematologic C
Conditions: Acute Myeloid Leukemia - Acute Lymphocytic Leukemia - Chronic Myelogenous Leukemia - Myelofibrosis - MDS - Refractory Anemia - Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Multiple Myeloma - Non-Hodgkin's Lymphoma - Leukemia - Lymphoma - Multi
1 Location available
- Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates
Conditions: Multiple Myeloma
1 Location available
- Stem Cell Transplantation To Treat High Risk Lymphoid Diseases With Reduced Toxicity Myeloablative Conditioning Regimen
Conditions: Multiple Myeloma - Plasma Cell Leukemia - Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- Fludarabine, Busulfan, and Alemtuzumab Followed By Donor Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Precancerous Condition
2 Locations available
- Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Pa
1 Location available
- Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Un
4 Locations available
- Panobinostat/Velcade in Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Studying Fentanyl in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Pr
1 Location available
- Study of Oral MLN9708 in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
Conditions: Relapsed and Refractory Multiple Myeloma
5 Locations available
- Donor Stem Cell Transplant After Total-Body Irradiation in Treating Patients With Relapsed or Refractory Hematologic Cancer or Acute Myeloid Leukemia
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- A Study of the Combination Vorinostat With Lenalidomide, Bortezomib and Dexamethasone for Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma
2 Locations available
- Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma
Conditions: Multiple Myeloma - Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
2 Locations available
- Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Au
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
88 Locations available
- Combined Haploidentical-Cord Blood Transplantation for Adults and Children
Conditions: Leukemia - Myelodysplastic Syndrome - Multiple Myeloma - Lymphoma
1 Location available
- Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Conditions: Breast Cancer - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Ovarian Cancer - Testicular Germ Cell Tumor
1 Location available
- Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Conditions: Chronic Lymphocytic Leukemia - Lymphoma, Non-Hodgkin - Acute Myeloid Leukemia - Multiple Myeloma
10 Locations available
- Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM
Conditions: Multiple Myeloma
1 Location available
- HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Tr
Conditions: Acute Lymphoblastic Leukemia - Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Multiple Myeloma
1 Location available
- A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer
Conditions: Lymphoma - Non-Hodgkin's Lymphoma - Hodgkin Disease - Multiple Myeloma - Leukemia - Lymphocytic - Chronic
5 Locations available
- Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Advanced Lymphoma, Multiple Myeloma, or Solid Tumors
Conditions: Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Precancerous Condition - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Conditions: Cancer - Hematologic Malignancies - Multiple Myeloma - Oncology - Bone Metastases - Multiple Myeloma Bone Lesions
9 Locations available
- Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
Conditions: Relapsed Multiple Myeloma
6 Locations available
- Study of Oral MLN9708 in Combination With Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma
13 Locations available
- Reduced Intensity Double Umbilical Cord Blood Transplantation
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Lymphoma - Multiple Myeloma - Chronic Lymphocytic Leukemia - Acute Myelogenous Leukemia
2 Locations available
- Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma
Conditions: Smoldering Multiple Myeloma
6 Locations available
- Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Stem Cell Transplantation for Patients With Multiple Myeloma
Conditions: Myeloma
1 Location available
- Defined Green Tea Catechin Extract in Treating Patients With Plasma Cell Neoplasm Or Smoldering Multiple Myeloma
Conditions: Monoclonal Gammopathy of Undetermined Significance - Smoldering Multiple Myeloma
1 Location available
- Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- A Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
Conditions: AML - ALL - CML in Blast Crisis - High-Risk MDS - Multiple Myeloma
5 Locations available
- A Study of Fixed Dose Radioimmunotherapy (Zevalin, Yttrium-90 Ibritumomab Tiuxetan) for Patients With Incomplete Response to Chemotherapy Prior to Aut
Conditions: Multiple Myeloma
1 Location available
- Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
Conditions: Multiple Myeloma
7 Locations available
- PH III Relapse or Refractory MM - Open Label With or Without Elotuzumab
Conditions: Multiple Myeloma
39 Locations available
- A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) Patients
Conditions: Multiple Myeloma
2 Locations available
- Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation
Conditions: Non-Hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma
4 Locations available
- A Study of LY2812176 in Multiple Myeloma or Advanced Solid Tumors
Conditions: Multiple Myeloma - Solid Tumors
1 Location available
- Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma
Conditions: Multiple Myeloma
4 Locations available
- Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma
Conditions: Thrombocytopenia - Multiple Myeloma
2 Locations available
- Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
Conditions: Multiple Myeloma
41 Locations available
- Phase I Study of CS-7017 and Bexarotene
Conditions: Solid Tumors - Lymphoma - Multiple Myeloma
1 Location available
- Chemotherapy and Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Disease or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplan
Conditions: Chronic Myeloproliferative Disorders - Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Oral Complications - Ovarian Cancer - Pain
1 Location available
- Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
Conditions: Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Precancerous Condition
1 Location available
- Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Secondary Myelofibrosis - Small Intestine Cance
1 Location available
- Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
401 Locations available
- Inflammatory Cytokines in Symptom Production in Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
- Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
Conditions: Non-Hodgkin's Lymphoma - Leukemia - Multiple Myeloma - Myeloproliferative Disorder
1 Location available
- Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
Conditions: Hematologic Malignancies, Multiple Myeloma, Lymphoma
2 Locations available
- Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Conditions: Multiple Myeloma - Plasma Cell Neoplasm
9 Locations available
- Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell
Conditions: Multiple Myeloma
1 Location available
- Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma
4 Locations available
- Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection
Conditions: Multiple Myeloma - Non-Hodgkins Lymphoma
1 Location available
- Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma
Conditions: Multiple Myeloma
1 Location available
|